Cited by 57Temporomandibular Joint DisordersMusculoskeletal pain and rehabilitationMyofascial pain diagnosis and treatment

Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials

Open access
Yao, Liang, Sadeghirad, Behnam, Li, Meixuan, Li, Jing, Wang, Qi, Crandon, Holly N, Martin, Grace, Morgan, Rebecca +16 more·2023·BMJ

Abstract

Objective: We explored the comparative effectiveness of available therapies for chronic pain associated with temporomandibular disorders (TMD). Design: Systematic review and network meta-analysis of randomised clinical trials (RCTs). Data sources: MEDLINE, EMBASE, CINAHL, CENTRAL, and SCOPUS were searched to May 2021, and again in January 2023. Study selection: Interventional RCTs that enrolled patients presenting with chronic pain associated with TMD. Data extraction and synthesis: Pairs of reviewers independently identified eligible studies, extracted data, and assessed risk of bias. We captured all reported patient-important outcomes, including pain relief, physical functioning, emotional functioning, role functioning, social functioning, sleep quality, and adverse events. We conducted frequentist network meta-analyses to summarise the evidence and used the GRADE approach to rate the certainty of evidence and categorise interventions from most to least beneficial. Results: 233 trials proved eligible for review, of which 153—enrolling 8713 participants and exploring 59 interventions or combinations of interventions—were included in network meta-analyses. All subsequent effects refer to comparisons with placebo or sham procedures. Effects on pain for eight interventions were supported by high to moderate certainty evidence. The three therapies probably most effective for pain relief were cognitive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy (risk difference (RD) for achieving the minimally important difference (MID) in pain relief of 1 cm on a 10 cm visual analogue scale: 36% (95% CI 33 to 39)), therapist-assisted jaw mobilisation (RD 36% (95% CI 31 to 40)), and manual trigger point therapy (RD 32% (29 to 34)). Five interventions were less effective, yet more effective than placebo, showing RDs ranging between 23% and 30%: CBT, supervised postural exercise, supervised jaw exercise and stretching, supervised jaw exercise and stretching with manual trigger point therapy, and usual care (such as home exercises, self stretching, reassurance). Moderate certainty evidence showed four interventions probably improved physical functioning: supervised jaw exercise and stretching (RD for achieving the MID of 5 points on the short form-36 physical component summary score: 43% (95% CI 33 to 51)), manipulation (RD 43% (25 to 56)), acupuncture (RD 42% (33 to 50)), and supervised jaw exercise and mobilisation (RD 36% (19 to 51)). The evidence for pain relief or physical functioning among other interventions, and all evidence for adverse events, was low or very low certainty. Conclusion: When restricted to moderate or high certainty evidence, interventions that promote coping and encourage movement and activity were found to be most effective for reducing chronic TMD pain. Registration: PROSPERO (CRD42021258567)

AI snapshot

Written from the paper’s full text.

TL;DR

In this systematic review and network meta-analysis of 153 randomised trials (8713 patients), moderate certainty evidence showed that CBT augmented with biofeedback or relaxation therapy, therapist-assisted jaw mobilisation, and manual trigger point therapy were among the most effective interventions for chronic pain associated with temporomandibular disorders. Most other interventions, and all evidence on adverse events, were supported by only low or very low certainty evidence.

Key findings

  • The review included 153 studies from 172 references, enrolling 8713 patients with chronic TMD pain; pain outcomes came from 148 RCTs (7867 patients), physical functioning from 33 RCTs (1910 patients), and adverse events from 31 studies (1987 patients).
  • For pain relief versus placebo/sham, moderate to high certainty evidence supported augmented CBT (risk difference for achieving ≥MID 36%, 95% CI 33 to 39), therapist-assisted jaw mobilisation (36%, 31 to 40), and manual trigger point therapy (32%, 29 to 34); five less effective but still superior-to-placebo interventions included CBT (30%, 23 to 35), supervised postural exercise (26%, 14 to 34), supervised jaw exercise with stretching (26%, 20 to 31), usual care (25%, 22 to 28), and jaw exercise with stretching plus trigger point therapy (23%, 11 to 31).
  • For physical functioning versus placebo/sham, moderate certainty evidence supported supervised jaw exercise with stretching (RD 43%, 33 to 51), manipulation (43%, 25 to 56), acupuncture (42%, 33 to 50), and supervised jaw exercise with mobilisation (36%, 19 to 51).
  • Certainty in effects on adverse events was low or very low for all 19 interventions reporting them.

Methods

  • Systematic review and network meta-analysis of randomised trials, reported per PRISMA-NMA and registered with PROSPERO (CRD42021258567); databases searched included MEDLINE, EMBASE, CINAHL, CENTRAL, and SCOPUS from inception through May 2021, with an update to January 2023.
  • Eligible trials were English-language, enrolled adults (≥18 years) with chronic TMD pain (≥3 months or author-defined chronic), randomised to active treatment, alternative treatment, placebo, sham, or usual care, and included at least 10 participants per treatment group.
  • Analyses used DerSimonian-Laird random-effects models; pain was converted to a 10 cm visual analogue scale and physical functioning to the 100-point SF-36 physical component summary; GRADE was used for certainty, and a minimally contextualised framework categorised interventions using risk differences for achieving the minimally important difference (1 cm for pain, 5 points for physical function).

Limitations

  • The paper states limited direct evidence for several interventions versus placebo/sham, most evidence was low or very low certainty, and all adverse event evidence was low or very low; it could not explore TMD subtype subgroup effects because most trials enrolled mixed subtypes or did not report subtype proportions.
  • The paper also states generalisability is uncertain because most trials excluded patients with comorbid mental illness, fibromyalgia, rheumatoid arthritis, or prior TMD surgery; data on litigation or disability benefits were insufficient; the blinding assumption could not be directly tested; and risk-difference modelling assumed equal standard deviations and normally distributed change scores.
  • Evident from the text: adverse events were reported in only 31 of 153 studies, networks could not be constructed for mental functioning, role functioning, social functioning, or sleep quality due to small numbers of trials, and 13 additional eligible trials from the updated search were not included in pooled estimates to maintain consistency with the guideline panel’s evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmj-2023-076226

Cites

57 of 58 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

9 of 25 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Meta-epidemiological studies found little to no effect of blinding on treatment results among randomised trials, including a review of oral health trials.

    “based on meta-epidemiological studies [22][23][24][25] that found little to no effect of blinding on treatment results among randomised trials (including a review of oral health trials 26 )”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [22] source

      The Discussion reports no evidence of an average difference in estimated treatment effects between blinded and non-blinded randomised trials. Its “Other studies” section says an oral-health trial study found no evidence of an effect from blinding outcome assessors, but some evidence of a moderate effect from blinding patients. Thus the unqualified “little to no effect” summary misses an important exception for oral-health trials. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [23] source

      The Results (page unavailable) report negligible or little evidence of bias from lack of blinding for several analyses, including outcomes analysed together. But the same section reports exaggerated treatment effects when subjective outcomes were assessed without blinding, so the unqualified claim of little to no effect overstates the review. The oral-health review is attached to a separate citation in the citing sentence. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [24] source
  • Premisecitation

    There have been nine prior network meta-analyses of interventions for chronic temporomandibular disorder pain.

    “There have been nine prior network meta-analyses (NMAs) of interventions for chronic TMD pain.[6][7][8][9][10][11][12][13][14]”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [6] source
    • cites [7] source
    • cites [8] source
  • Findingown data

    In total, 148 RCTs involving 7867 patients and evaluating 59 interventions reported effects on pain.

    “In total, 148 RCTs involving 7867 patients and evaluating 59 interventions reported effects on pain (fig 2).”
    Quote in the paperSubstantial claim
  • Findingown data

    The updated literature search in January 2023 identified 13 additional eligible trials that enrolled a total of 875 patients.

    “Our updated literature search in January 2023, identified 13 additional eligible trials that enrolled a total of 875 patients”
    Quote in the paperNot a substantial claim
  • Findingown data

    In the 31 direct comparisons with two or more studies available for conventional pairwise meta-analysis, there was substantial heterogeneity (I2 >70%) for 11 comparisons.

    “In the 31 direct comparisons with two or more studies available for conventional pairwise metaanalysis, there was substantial heterogeneity (I 2 >70%) for 11 comparisons”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. 26
  • May combine two claims. 27
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim.

    Study design and conductown data

    The GRADE approach was used to assess the certainty of evidence for direct, indirect, and network estimates for all outcomes.

    “We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the certainty of evidence for direct, indirect, and network estimates for all outcomes.”
    Quote in the paperSubstantial claim1 of 1 sources checked
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    The design-by-treatment model (global test) was used to assess the coherence assumption for each network.

    “We used the”
    Quote in the paperSubstantial claim1 of 1 sources checked
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    The credibility of statistically significant subgroup effects was assessed using the Instrument to assess the Credibility of Effect Modification Analyse (ICEMAN) criteria.

    “We assessed the credibility of statistically significant subgroup effects (P value for test of interaction <0.05) using Instrument to assess the Credibility of Effect Modification Analyse (ICEMAN) criteria.43”
    Quote in the paperNot a substantial claim1 of 1 sources checked
  • May combine two claims.

    Premisecitation

    Using SUCRA rankings to identify the most promising interventions is often misleading because it considers only the point estimate of effect and not the associated precision or certainty of evidence and ignores absolute differences between treatment alternatives.

    “This approach is often misleading, as it considers only the point estimate of effect and not the associated precision or certainty of evidence and ignores absolute differences between treatment alternatives.[56][57][58]”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [56] source

      The section “Five reasons why these rankings may mislead if not interpreted correctly” says SUCRA rankings can be misleading because they do not capture certainty, the magnitude of differences between treatments, or whether apparent differences are due to chance. But “Ranking treatments” describes SUCRA as a measure of the likelihood that a treatment occupies a high rank, not as considering only a point estimate; that part of the claim is not supported. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [57] source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [58] source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingreasoning

    The meta-analyses included 153 studies from 172 references, which enrolled 8713 patients with chronic TMD pain.

    “Thus, our meta-analyses included 153 studies from 172 references, which enrolled 8713 patients with chronic TMD pain.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Studies eligible for the review were parallel trials that evaluated 23 conservative interventions, 15 pharmacological interventions, seven combinations of pharmacological and conservative interventions, 13 surgical interventions with or without adjunct treatments, and placebo/sham procedures.

    “Studies eligible for our review were parallel trials that evaluated 23 conservative interventions, 15 pharmacological interventions, seven combinations of pharmacological and conservative interventions, 13 surgical interventions with or without adjunct treatments, and placebo/sham procedures”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The search identified 9033 unique citations, of which 233 (reporting 210 unique trials) proved eligible for review.

    “Our search identified 9033 unique citations, of which 233 (reporting 210 unique trials) proved eligible for review (fig 1).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The median follow-up was 12 weeks (5-52).

    “The median follow-up was 12 weeks (5-52).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Most trials (126; 82%) reported <20% missing outcome data.

    “Most trials (126; 82%) reported <20% missing outcome data.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Approximately a third of trials explicitly excluded TMD patients with comorbid rheumatoid arthritis (36%) or prior TMJ surgery (32%), and 20% excluded those with comorbid fibromyalgia; only a single trial reported enrolling any patients with these features.

    “Approximately a third of trials explicitly excluded TMD patients with comorbid rheumatoid arthritis (36%) or prior TMJ surgery (32%), and 20% excluded those with comorbid fibromyalgia; only a single trial reported enrolling any patients with these features”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The overall risk of bias was rated high in 96 (63%) studies, and low or probably low in 57 (37%) studies.

    “We rated the overall risk as high in 96 (63%) studies, and low or probably low in 57 (37%) studies (supplement table 7).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The median sample size of included trials was 46 (interquartile range 35-63).

    “The median sample size of included trials was 46 (interquartile range 35-63)”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Almost half of all trials (47%) excluded TMD patients with comorbid mental illness, and only three trials (2%) reported enrolling such patients.

    “Almost half of all trials (47%) excluded TMD patients with comorbid mental illness, and only three trials (2%) reported enrolling such patients.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    65 studies (42%) blinded patients.

    “65 (42%) blinded patients”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The median of the mean age among patients was 35 years (30-39).

    “the median of the mean age among patients was 35 years (30-39).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Most trials provided no details on funding (44%) or declared non-industry funding (41%), with the remainder reporting no funding (15%).

    “Most trials provided no details on funding (44%) or declared non-industry funding (41%), with the remainder reporting no funding (15%) (table 1).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The median average pain duration when reported was 44 months (13-65).

    “the median average pain duration when reported was 44 months (13-65).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    65 studies (42%) blinded outcome assessors.

    “65 (42%) blinded outcome assessors”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    48 studies (31%) blinded healthcare providers.

    “48 (31%) blinded healthcare providers”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Half of trials (75/153, 49%) enrolled patients with a specific subtype of TMD, most often myofascial TMD (38/75, 51%).

    “Half of trials (75/153, 49%) enrolled patients with a specific subtype of TMD (most often myofascial TMD (38/75, 51%))”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingcitation

    The median average pain score at baseline was 5.4 cm (4.3-6.6) on a 10 cm visual analogue scale, which equates to moderate severity pain.

    “The median average pain score at baseline was 5.4 cm (4.3-6.6) on a 10 cm visual analogue scale, which equates to moderate severity pain, 52”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [52] source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.

    Findingown data

    Supervised jaw exercise and stretching without manual trigger point therapy is less effective than the most effective therapies but more effective than placebo for pain relief in chronic temporomandibular disorders, based on moderate to high certainty evidence.

    “Moderate to high certainty evidence showed that five interventions were less effective, yet more effective than placebo for pain relief: CBT, supervised postural exercise, supervised jaw exercise and stretching with or without manual trigger point therapy, and usual care”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Supervised jaw exercise and stretching with manual trigger point therapy is less effective than the most effective therapies but more effective than placebo for pain relief in chronic temporomandibular disorders, based on moderate to high certainty evidence.

    “Moderate to high certainty evidence showed that five interventions were less effective, yet more effective than placebo for pain relief: CBT, supervised postural exercise, supervised jaw exercise and stretching with or without manual trigger point therapy, and usual care”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The 33 RCTs included 44 direct comparisons, of which 12 included two or more studies for conventional pairwise meta-analysis and one showed substantial heterogeneity.

    “The 33 RCTs included 44 direct comparisons, of which 12 included two or more studies for conventional pairwise meta-analysis and one showed substantial heterogeneity”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Cognitive behavioural therapy is less effective than the most effective therapies but more effective than placebo for pain relief in chronic temporomandibular disorders, based on moderate to high certainty evidence.

    “Moderate to high certainty evidence showed that five interventions were less effective, yet more effective than placebo for pain relief: CBT, supervised postural exercise, supervised jaw exercise and stretching with or without manual trigger point therapy, and usual care”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Despite the large overall number of trials and participants, the review found limited direct evidence to inform the effectiveness of several interventions versus placebo or sham procedures, and the evidence to inform the effectiveness of most interventions proved to be of low or very low certainty, including all evidence to inform adverse events.

    “despite the large overall number of trials and participants, we found limited direct evidence to inform the effectiveness of several interventions versus placebo/ sham procedures, and the evidence to inform the effectiveness of most interventions proved to be of low or very low certainty, including all evidence to inform adverse events.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Supervised postural exercise is less effective than the most effective therapies but more effective than placebo for pain relief in chronic temporomandibular disorders, based on moderate to high certainty evidence.

    “Moderate to high certainty evidence showed that five interventions were less effective, yet more effective than placebo for pain relief: CBT, supervised postural exercise, supervised jaw exercise and stretching with or without manual trigger point therapy, and usual care”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Usual care is less effective than the most effective therapies but more effective than placebo for pain relief in chronic temporomandibular disorders, based on moderate to high certainty evidence.

    “Moderate to high certainty evidence showed that five interventions were less effective, yet more effective than placebo for pain relief: CBT, supervised postural exercise, supervised jaw exercise and stretching with or without manual trigger point therapy, and usual care”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Pairs of reviewers independently abstracted data from each eligible article.

    “Pairs of reviewers independently abstracted the following data from each eligible article”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The review protocol was registered with PROSPERO (CRD42021258567).

    “registered our review protocol with PROSPERO (CRD42021258567).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    The review followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension statement for reporting of systematic reviews incorporating network meta-analyses.

    “We followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension statement for reporting of systematic reviews incorporating NMAs 17”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [17] source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Pairs of trained reviewers screened titles and abstracts of identified citations independently and in duplicate.

    “Pairs of trained reviewers screened titles and abstracts of identified citations independently and in duplicate, using a standardised, pilot-tested form”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The side-splitting method was used to evaluate local (loop-specific) incoherence in each closed loop of the network.

    “We used the side-splitting method to evaluate local (loop-specific) incoherence in each closed loop of the network as the difference between”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 34 35

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Study design and conductown data

    We were unable to explore subtype of TMD as an effect modifier because most trials enrolled mixed subtypes and reported aggregate results or did not report which subtype(s) were enrolled.

    “We were unable to explore subtype of TMD as an effect modifier as most trials enrolled mixed subtypes and reported aggregate results or did not report which subtype(s) were enrolled.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The three therapies probably most effective for pain relief were cognitive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy, therapist-assisted jaw mobilisation, and manual trigger point therapy.

    “The three therapies probably most effective for pain relief were cognitive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy (modelled risk difference (RD) for achieving the minimally important difference in pain relief of 1 cm on a 10 cm scale 36% (95% CI 33 to 39)), therapist-assisted jaw mobilisation (RD 36% (31 to 40)), and manual trigger point therapy (RD 32% (29 to 3”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    When at least 10 trials were available for a direct comparison, small-study effects were assessed using Harbord's test for binary outcomes and Egger's test for continuous outcomes.

    “When at least 10 trials were available for a direct comparison, we assessed small-study effects using Harbord's test for binary outcomes and Egger's test for continuous outcomes.30 31”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites 30 31

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Pairs of reviewers independently assessed the risk of bias among eligible studies using a modified Cochrane risk of bias instrument.

    “Pairs of reviewers independently assessed the risk of bias among eligible studies using a modified Cochrane risk of bias instrument”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All interventions were reviewed and categorised by two or more clinical experts, independently and blinded to study results.

    “All interventions were reviewed and categorised by two or more clinical experts, independently and blinded to study results”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    There was no evidence of global or loop-specific incoherence in the network.

    “We found no evidence of global or loop-specific incoherence (supplement table 16).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning

    Findings were highly variable across prior reviews, and each network meta-analysis identified its most promising interventions based on SUCRA rankings.

    “Findings were highly variable across reviews, and each NMA identified their most promising interventions based on SUCRA rankings.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    A 2022 Cochrane review of 12 randomised controlled trials found low certainty evidence from five trials that cognitive behavioural therapy may reduce pain intensity at longest follow-up, but the effect estimate was associated with substantial imprecision.

    “A 2022 Cochrane review of 12 RCTs assessed treatment effects of psychological therapies for chronic TMD pain and found low certainty evidence from five trials that cognitive behavioural therapy (CBT) may reduce pain intensity at longest follow-up; however, the effect estimate was associated with substantial imprecision.59”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [59] Penlington, 2022, Psychological therapies for temporomandibular disorders (TMDs), Cochrane Database Syst Rev source
  • May combine two claims.

    Study design and conductown data

    The review was unable to explore subgroup effects based on subtypes of temporomandibular disorders or receipt of disability benefits or litigation because of insufficient variability among eligible trials.

    “we were unable to explore for subgroup effects as most trials eligible for our review enrolled mixed subtypes or did not report the proportion of TMD subtypes among patients and reported aggregate results.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Diagnostic criteria for temporomandibular disorder subtypes are largely subjective and patients often satisfy criteria for multiple subtypes.

    “diagnostic criteria for TMD subtypes are largely subjective and patients often satisfy criteria for multiple subtypes.53 54”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [53] source
    • cites [54] Lobbezoo-Scholte, 1995, Diagnostic subgroups of craniomandibular disorders. Part II: Symptom profiles, J Orofac Pain
  • May combine two claims.

    Interpretationown data

    Five interventions were less effective than the top three but more effective than placebo/sham: cognitive behavioural therapy, supervised postural exercise, supervised jaw exercise with stretching, usual care, and supervised jaw exercise with stretching and manual trigger point therapy.

    “Five interventions were less effective, yet more effective than placebo/sham procedures: cognitive behavioural therapy (RD 30% (23 to 35)), supervised postural exercise (RD 26% (14 to 34)), supervised jaw exercise with stretching (RD 26% (20 to 31)), usual care (such as home exercises, stretching, reassurance, self massage, and education) (RD 25% (22 to 28)), and supervised jaw exercise with”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    The review used the GRADE approach to evaluate the certainty of evidence and ranked interventions using a minimally contextualised approach that considers both the magnitude of effects and certainty of evidence.

    “we used the GRADE approach to evaluate the certainty of evidence and ranked interventions using a minimally contextualised approach that considers both the magnitude of effects and certainty of evidence.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Independent coding of interventions by clinical experts blinded to study results provides reassurances regarding the composition of the network treatment nodes.

    “Independent coding of interventions by clinical experts blinded to study results provides reassurances regarding the composition of our network treatment nodes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    Of the 20 direct comparisons that contributed to the network, four had two or more studies for pairwise meta-analysis, and none showed substantial heterogeneity.

    “Of the 20 direct comparisons that contributed to our network, four had two or more studies for pairwise meta-analysis, and none showed substantial heterogeneity”
    Quote in the paperNot a substantial claim
47 of 47
  • The authors state this as an assumption.

    Treatment effects are similar across different temporomandibular disorder subtypes.

    “a key assumption of our review is that treatment effects would be similar across different TMD subtypes”
  • The authors state this as an assumption.

    Blinding has little to no effect on treatment results among randomised trials, including the trials in this review.

    “we could not directly test this assumption”
    “based on meta-epidemiological studies [22][23][24][25] that found little to no effect of blinding on treatment results among randomised trials”
  • The authors state this as an assumption.

    The standard deviations of outcome measures are the same in both the treatment and control groups.

    “modelling assumptions for estimating the risk difference of achieving the minimally important difference assume that the standard deviations of outcome measures are the same in both the treatment and control groups”
  • The authors state this as an assumption.

    Change scores in both the treatment and control groups are normally distributed.

    “and that change scores in both groups are normally distributed”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The linked systematic review included 210 studies (233 publications), of which 153 trials (8713 participants) were included in network meta-analyses.

    “The linked systematic review included 210 studies (in 233 publications), of which 153 trials (8713 participants) were included in network meta-analyses.”

    From Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline (2023) · cites this paper as [1]

    The Results report 233 publications covering 210 eligible trials, and 153 studies enrolling 8713 patients in the meta-analyses. However, the study-selection figure labels the quantitative synthesis as including both network and conventional meta-analysis; the copy does not establish that all 153 trials were included in network meta-analyses specifically. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The draft summary of findings was prepared prior to the panel meetings, following GRADE guidance from the accompanying network meta-analysis.

    “The draft summary of findings were prepared prior to the panel meetings, following GRADE guidance from the accompanying network meta-analysis. 1”

    From Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline (2023) · cites this paper as [1]

    The Certainty of evidence section says the network meta-analysis followed GRADE guidance for communicating its findings, and the Additional analysis section identifies a summary of findings. Neither section, nor the Guideline panel involvement section, says a draft summary was prepared before panel meetings. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The included trials reported the effects of 59 interventions or combinations compared with placebo or sham procedures in patients with chronic temporomandibular disorder pain.

    “These trials reported the effects of 59 interventions, or combinations of interventions, when compared with placebo or sham procedures in patients with chronic pain associated with temporomandibular disorders (TMD).”
  • The recommendations are based on a linked systematic review and network meta-analysis.

    “Our recommendations are based on a linked systematic review and network meta-analysis (see box 1). 1”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Publication-year categories omit the stated final year

    Minor

    The table gives a publication range ending in 2021, but its exhaustive year categories end in 2020 and already account for all 153 included studies.

1 of 1

Cites

Flagged first, then by citations

1 of the 59 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yao, L., Sadeghirad, B., Li, M., Li, J., Wang, Q., Crandon, H. N., Martin, G., Morgan, R., Florez, I. D., Hunskaar, B. S., Wells, J., Moradi, S., Zhu, Y., Ahmed, M. M., Gao, Y., Cao, L., Yang, K., Tian, J., Li, J., Zhong, L., Couban, R. J., Guyatt, G. H., Agoritsas, T., & Busse, J. W.
Affiliations
  • McMaster University (CA)
  • Lanzhou University (CN)
  • University of Toronto (CA)
  • Case Western Reserve University (US)
  • Department of Pediatrics, University of Antioquia, Medellin, Colombia.
  • University of Oslo (NO)
  • Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic, Cleveland, OH, USA
  • Sichuan University (CN)
  • Nanyang Technological University (SG)
  • University Hospital of Geneva (CH)
Corresponding author
Yang, Kehu
Venue
BMJ
Publisher
BMJ
Published
2023-12-15
Volume
383
Pages
e076226
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4389781613
Cited by
57
References
59
Citations by year
2026: 22 · 2025: 19 · 2024: 14 · 2023: 2
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by-nc)
  • DR-NTU (Nanyang Technological University) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • McMaster University
  • Lanzhou University
  • University of Toronto
  • Canadian Institutes of Health Research
  • Chronic Pain Centre of Excellence for Canadian Veterans
Topics
  • Health Sciences › Health Professions › Complementary and Manual Therapy › Temporomandibular Joint Disorders
  • Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Myofascial pain diagnosis and treatment
Keywords
temporomandibular disorders, chronic pain, comparative effectiveness, cognitive behavioral therapy, biofeedback, relaxation training, postural exercises, manipulation, transcutaneous electrical nerve stimulation, myofascial release, physical function, sleep quality, adverse events, home-based exercise
MeSH terms
Network Meta-Analysis, Exercise Therapy, Humans, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Physical Therapy Modalities, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-12.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-12.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review